Literature DB >> 1591996

Two myogenic lineages within the developing somite.

C P Ordahl1, N M Le Douarin.   

Abstract

It is well known that the muscles of the vertebrate body are derived from the somite. Precursor cells within the somite proper form the back or axial muscles while other precursor cells migrate away from the somite to populate the muscle of the limbs and ventral body wall. Although both types of muscle are generally thought of as arising from a common progenitor population, the myotome, recent evidence points to developmental differences in these two groups of muscles which may reflect different developmental lineages. To test the lineage hypothesis, we used microsurgery and the chick-quail nucleolar marker system to follow the developmental fate of the lateral and medial halves of somites at the wing level. The results showed that the structures of the mature somite (myotome and sclerotome) are derived virtually exclusively from cells residing in the medial half of the newly formed somite. On the other hand, virtually all of the cells residing in the lateral half of the newly formed somite are destined to leave the somite proper and populate the limb muscle and, probably, other somite-derived mesenchymal structures in the limb and ventral body wall. Switch-graft experiments show that the two halves of newly formed somites are largely interchangeable demonstrating that their ultimate developmental fate is position-dependent and that it becomes fixed as a result of extrinsic influences which act during later stages of somitogenesis. We conclude that at least two distinct myogenic lineages exist in the somite; one giving rise to the muscles of the back and the other giving rise to the limb musculature.

Entities:  

Mesh:

Year:  1992        PMID: 1591996     DOI: 10.1242/dev.114.2.339

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  87 in total

1.  Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.

Authors:  T A Heanue; R Reshef; R J Davis; G Mardon; G Oliver; S Tomarev; A B Lassar; C J Tabin
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  Activation of myogenesis by the homeobox gene Lbx1 requires cell proliferation.

Authors:  D Mennerich; T Braun
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Tendon morphogenesis in the developing avian limb: plasticity of fetal tendon fibroblasts.

Authors:  Sarah F Oldfield; Darrell J R Evans
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

4.  Local signalling in dermomyotomal cell type specification.

Authors:  B Christ; B Brand-Saberi; M Grim; J Wilting
Journal:  Anat Embryol (Berl)       Date:  1992-10

Review 5.  Regional differences in neural crest morphogenesis.

Authors:  Bryan R Kuo; Carol A Erickson
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

6.  Inducible lineage tracing of Pax7-descendant cells reveals embryonic origin of adult satellite cells.

Authors:  Christoph Lepper; Chen-Ming Fan
Journal:  Genesis       Date:  2010-07       Impact factor: 2.487

Review 7.  Relations and interactions between cranial mesoderm and neural crest populations.

Authors:  Drew M Noden; Paul A Trainor
Journal:  J Anat       Date:  2005-11       Impact factor: 2.610

8.  Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development.

Authors:  H Takayama; W J La Rochelle; M Anver; D E Bockman; G Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

9.  Lineage-specific responses to reduced embryonic Pax3 expression levels.

Authors:  Hong-Ming Zhou; Jian Wang; Rhonda Rogers; Simon J Conway
Journal:  Dev Biol       Date:  2007-12-27       Impact factor: 3.582

10.  Mouse limb muscle is determined in the absence of the earliest myogenic factor myf-5.

Authors:  S Tajbakhsh; M E Buckingham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.